Douglas Blakely
Chief Executive Officer at Technologies for Medicine
Profile
Douglas Blakely is Vice President of Sales and Marketing for Endothelix, Inc. He is President and Chief Executive Officer of Technologies For Medicine.
Previously, he worked at Healthcare Industry for over 20 years.
He held various executive management positions in the Medical Device Industry.
Mr. Blakely received an Engineering degree in Geophysics and Geosciences from Texas Tech University in 1985.
Douglas Blakely active positions
Companies | Position | Start |
---|---|---|
Technologies for Medicine | Chief Executive Officer | - |
Former positions of Douglas Blakely
Companies | Position | End |
---|---|---|
Endothelix, Inc.
Endothelix, Inc. Medical SpecialtiesHealth Technology Endothelix, Inc. develops cardiovascular devices. It focuses on non-invasive vascular function measurement. The firm's product VENDYS is a non-invasive and inexpensive vascular function test that help physicians assess and monitor patients cardiovascular health and use appropriate therapies for the prevention and treatment of heart disease and stroke. The company was founded by Morteza Naghavi and Asif Ali in 2003 and is headquartered in Bellaire, TX. | Sales & Marketing | - |
Training of Douglas Blakely
Texas Tech University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Endothelix, Inc.
Endothelix, Inc. Medical SpecialtiesHealth Technology Endothelix, Inc. develops cardiovascular devices. It focuses on non-invasive vascular function measurement. The firm's product VENDYS is a non-invasive and inexpensive vascular function test that help physicians assess and monitor patients cardiovascular health and use appropriate therapies for the prevention and treatment of heart disease and stroke. The company was founded by Morteza Naghavi and Asif Ali in 2003 and is headquartered in Bellaire, TX. | Health Technology |
Technologies for Medicine |
- Stock Market
- Insiders
- Douglas Blakely